Legend Biotech Corporation (LEGN)

NASDAQ: LEGN · Real-Time Price · USD

38.80

-0.27 (-0.69%)

At close: Aug 1, 2025, 4:00 PM

38.99

+0.19 (0.49%)

After-hours: Aug 1, 2025, 7:45 PM EDT

Legend Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2020
Operating Revenue	725.29	620.98	284.96	116.68	65.4	75	Upgrade
Other Revenue	3.02	6.26	0.18	0.33	3.42	-	Upgrade
Revenue	728.3	627.24	285.14	117.01	68.83	75	Upgrade
Revenue Growth (YoY)	112.46%	119.97%	143.70%	70.00%	-8.23%	21.36%	Upgrade
Cost of Revenue	665.69	648.13	526.43	401.01	313.35	232.16	Upgrade
Gross Profit	62.61	-20.88	-241.29	-284.01	-244.52	-157.16	Upgrade
Selling, General & Admin	300.54	284.26	200.93	174.05	149.5	72.71	Upgrade
Operating Expenses	300.54	284.26	200.93	174.05	149.5	72.71	Upgrade
Operating Income	-237.93	-305.15	-442.22	-458.05	-394.02	-229.87	Upgrade
Interest Expense	-21.2	-21.62	-21.79	-10.8	-0.9	-0.2	Upgrade
Interest & Investment Income	59.39	61.2	54.49	8.18	0.97	2.93	Upgrade
Currency Exchange Gain (Loss)	4.26	108.51	-28.65	-9.88	-	0.07	Upgrade
Other Non Operating Income (Expenses)	3.85	3.34	-82.61	24.22	-12.27	-1.23	Upgrade
EBT Excluding Unusual Items	-191.63	-153.71	-520.78	-446.33	-406.22	-228.29	Upgrade
Gain (Loss) on Sale of Investments	-0.45	-	0.66	0.6	-	0.05	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	-	-0.97	-0.06	Upgrade
Asset Writedown	-5.39	-4.42	-	-	-	-	Upgrade
Other Unusual Items	-	-	-	-	-	-79.98	Upgrade
Pretax Income	-197.48	-158.13	-520.12	-445.72	-407.2	-308.29	Upgrade
Income Tax Expense	20.67	18.89	-1.86	0.63	-3.61	-41.91	Upgrade
Net Income	-218.15	-177.03	-518.25	-446.35	-403.58	-266.37	Upgrade
Net Income to Common	-218.15	-177.03	-518.25	-446.35	-403.58	-266.37	Upgrade
Shares Outstanding (Basic)	183	183	176	159	141	118	Upgrade
Shares Outstanding (Diluted)	183	183	176	159	141	118	Upgrade
Shares Change (YoY)	1.67%	3.84%	10.71%	12.91%	19.21%	18.15%	Upgrade
EPS (Basic)	-1.19	-0.97	-2.94	-2.81	-2.87	-2.25	Upgrade
EPS (Diluted)	-1.19	-0.97	-2.94	-2.81	-2.87	-2.26	Upgrade
Free Cash Flow	-273.17	-158.14	-413.36	-222.21	-240.66	-249.26	Upgrade
Free Cash Flow Per Share	-1.49	-0.86	-2.35	-1.40	-1.71	-2.11	Upgrade
Gross Margin	8.60%	-3.33%	-84.62%	-242.73%	-	-209.55%	Upgrade
Operating Margin	-32.67%	-48.65%	-155.09%	-391.48%	-572.49%	-306.49%	Upgrade
Profit Margin	-29.95%	-28.22%	-181.75%	-381.48%	-586.38%	-355.16%	Upgrade
Free Cash Flow Margin	-37.51%	-25.21%	-144.97%	-189.91%	-349.67%	-332.34%	Upgrade
EBITDA	-228.34	-294.29	-431.48	-445.41	-385.88	-223.63	Upgrade
EBITDA Margin	-31.35%	-46.92%	-151.32%	-	-	-298.18%	Upgrade
D&A For EBITDA	9.59	10.86	10.73	12.65	8.14	6.23	Upgrade
EBIT	-237.93	-305.15	-442.22	-458.05	-394.02	-229.87	Upgrade
EBIT Margin	-32.67%	-48.65%	-155.09%	-	-	-	Upgrade
Revenue as Reported	728.3	627.24	285.14	117.01	68.83	75	Upgrade

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q